248.05 -7.00 (-2.74%)
1.9M NSE+BSE Volume
NSEAug 04, 2021 03:31 PM
Latest broker research reports with buy, sell, hold recommendations along with forecast target prices and upside. Browse thousands of reports and search by company or the broker.
|Summary||Date||Stock||Broker||Price at Reco.||Target||Price at reco|
Change since reco(%)
|2019-11-01||Fortis Healthcare Ltd. +||Ventura||150.85||150.85 (64.43%)||Buy|
|2018-04-02||Fortis Healthcare Ltd. +||Way2Wealth||127.90||127.90 (93.94%)|
Fortis Healthcare Limited is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise of hospitals, diagnostics and day care specialty facilities. Currently, the company...
|2018-03-16||Fortis Healthcare Ltd. +||ICICI Securities Limited||155.55||195.00||155.55 (59.47%)||Buy|
|2018-03-01||Fortis Healthcare Ltd. +||Motilal Oswal||159.60||185.00||159.60 (55.42%)||Buy|
Fortis Healthcare (FORH) reported 2QFY18/3QFY18 revenue of INR12b (flat YoY)/INR11.2b (-1.1% YoY), with EBIDTA margin of 8.9%/4.6%. Hospital business revenue came in at INR9.7b (-0.6% YoY)/INR9b (-0.9% YoY) for2QFY18/3QFY18, with EBITDA margin of 8.5%/5.5%. SRL reported revenue ofINR2.2b (+5.2% YoY)/INR2.1b (+10% YoY), with EBITDA margin of 23.2%/18.4%.2Q numbers were in line, but 3Q numbers missed our expectations. FORH reported a loss of INR236m/INR191m in 2Q/3QFY18.
|2018-01-31||Fortis Healthcare Ltd. +||Geojit BNP Paribas||136.50||220.00||136.50 (81.72%)||Buy|
|2017-11-15||Fortis Healthcare Ltd. +||Motilal Oswal||140.45||185.00||140.45 (76.61%)||Buy|
Fortis (FORH) plans to acquire all the assets of RHT for INR46.5b. Net outflow for the company will be ~INR36b, as it owns ~30% stake in RHT (worth ~INR10-10.5b). RHT asset acquisition is expected to be value-accretive to the tune of ~INR3040/share. We maintain our Buy rating on FORH, with an SOTP-based TP of INR185/share. The court case between promoters and Daichi remains a key overhang on the stock. FORH has announced that it plans to acquire the entire portfolio of assets of Religare Health Trust (RHT), listed in Singapore, at an enterprise value of INR46.5b (including debt of INR11.52b). FORH and RHT have entered into an...
|2017-08-09||Fortis Healthcare Ltd. +||Axis Direct||158.65||191.00||158.65 (56.35%)||Buy|
|2017-07-03||Fortis Healthcare Ltd. +||Joindre Capital Services||217.00||Buy|
Joindre Capital Services
The Fortis network includes multi-speciality hospitals and super-speciality centres providing comprehensive tertiary and quaternary healthcare to patients across specialities such as cardiac care, orthopaedics, neurosciences, oncology, renal care, gastroenterology and mother & child care. Fortis runs one of the largest cardiac programmes in the world. It also has one of...
|2017-02-23||Fortis Healthcare Ltd. +||Axis Direct||195.65||198.00||195.65 (26.78%)||Target met||Hold|
Q3FY17 consolidated revenue at Rs 11 bn (up 10% YoY) driven by 9% YoY growth in hospital business at Rs 9.2 bn and 11% YoY growth in diagnostics business (SRL) at Rs 2 bn. EBITDA increased to Rs 1.1 bn mainly due to lower service fee (consolidation of FHTL). Consolidated PBT before forex and excepti..
|2014-02-17||Fortis Healthcare Ltd. +||ICICI Securities Limited||95.20||95.20 (160.56%)|